Capote-Puente Raúl, Sánchez-González José-María, Sánchez-González María Carmen, Bautista-Llamas María-José
Optica Area, Vision Research Group (CIVIUS), Department of Physics of Condensed Matter, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain.
Diagnostics (Basel). 2023 Mar 27;13(7):1258. doi: 10.3390/diagnostics13071258.
This study aimed to evaluate the non-invasive and subjective symptoms associated with Lehfilcon A water gradient silicone hydrogel contact lenses with bacterial and lipid resistance technology. A prospective, longitudinal, single-centre, self-controlled study was conducted among silicone hydrogel contact lens wearers. Non-invasive analysis of the pre-lens tear film was performed using the Integrated Clinical Platform (ICP) Ocular Surface Analyzer (OSA), and the meibomian glands were evaluated with the Cobra HD infrared meibographer. After 30 days of contact lens wear, the subjects were re-evaluated to determine the changes in conjunctival redness, subjective dry eye disease, tear meniscus height, lipid pattern, and non-invasive break-up time. Results showed that the lipid layer thickness decreased significantly from 2.05 ± 1.53 to 0.92 ± 1.09 Guillon patterns, and the tear meniscus height decreased from 0.21 ± 0.04 to 0.14 ± 0.03. The mean pre-lens non-invasive break-up time (NIBUT) significantly increased from 15.19 ± 9.54 to 25.31 ± 15.81 s. The standard Patient Evaluation of Eye Disease (SPEED) score also decreased from 7.39 ± 4.39 to 5.53 ± 4.83. The results suggest that Lehfilcon A significantly reduced lipid and aqueous tear film volume but improved break-up time and subjective dry eye symptoms.
本研究旨在评估采用抗细菌和抗脂质技术的Lehfilcon A水梯度硅水凝胶隐形眼镜相关的非侵入性和主观症状。在硅水凝胶隐形眼镜佩戴者中开展了一项前瞻性、纵向、单中心、自身对照研究。使用综合临床平台(ICP)眼表分析仪(OSA)对镜片前泪膜进行非侵入性分析,并用Cobra HD红外睑板腺成像仪评估睑板腺。佩戴隐形眼镜30天后,对受试者进行重新评估,以确定结膜充血、主观干眼疾病、泪河高度、脂质形态和非侵入性泪膜破裂时间的变化。结果显示,脂质层厚度从2.05±1.53 Guillon形态显著降至0.92±1.09 Guillon形态,泪河高度从0.21±0.04降至0.14±0.03。镜片前平均非侵入性泪膜破裂时间(NIBUT)从15.19±9.54秒显著增加至25.31±15.81秒。眼疾病标准患者评估(SPEED)评分也从7.39±4.39降至5.53±4.83。结果表明,Lehfilcon A显著减少了脂质和水性泪膜体积,但改善了泪膜破裂时间和主观干眼症状。